Cancer survivors face a 14% higher risk of developing entirely new cancers (secondary malignancies) compared to the general population, and they account for nearly 19% of all cancer diagnoses in the U.S. Oncology Advanced Practice Providers (APPs) highlight that past treatments, especially radiation and certain chemotherapies like alkylating agents, platinum-based drugs, anthracycline topoisomerase II inhibitors, and even targeted therapies, can contribute to long-term risk.

New research from a large study in Denmark and Sweden, shows that adult survivors of childhood cancer, including those treated for Hodgkin lymphoma, may be at greater risk for severe illness from COVID-19. This increased vulnerability is likely linked to lasting effects from cancer treatments, such as weakened immune systems or damage to organs like the lungs and heart.

For people newly diagnosed with advanced-stage classical Hodgkin lymphoma, choosing a first-line treatment can feel overwhelming. This article reviews the most widely used treatments, outlining how they compare in terms of both effectiveness and long-term side effects. The goal is not just remission but also protecting the quality of life for years to come.

WNYC’s Brian Lehrer Show featured an insightful panel discussion on the current landscape of cancer research in the United States.

A problem-solving skills training intervention reduced symptoms of stress and anxiety compared with usual care for young adults with cancer, according to results of a randomized trial presented at ASCO Annual Meeting.

The University of Cincinnati has launched one of the first oncology-focused primary care clinics specifically for Adolescent and Young Adult (AYA) cancer survivors, those diagnosed between the ages 18 and 39. This new model addresses the complex, long-term health risks survivors face, including second cancers, heart disease, and emotional challenges, by combining oncology knowledge with general preventive care. Early data shows high rates of chronic conditions and a strong need for coordinated, survivor-centered care.

An interview with Dr. Christopher Burke, a leading aortic valve surgeon at UW Medicine Heart Institute in Seattle, Washington, who has developed a successful Ross Procedure program.

Many cancer survivors experience fatigue and depression after treatment, and a new study presented at the American Association for Cancer Research’s annual meeting highlights just how common it is, especially among women.

Slate review of the April 14, 2025 article “CT Scans in a Single Year Could Result in 100,000 Future Cancers in the U.S.”

For many long-term Hodgkin’s survivors—especially those treated with high-dose radiation—any exposure to additional radiation can feel alarming. CT scans are incredibly useful tools, but do they carry real cancer risk?